These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 11655395)
41. California campuses resist industry restrictions. Check E Nature; 2007 Jul; 448(7152):394-5. PubMed ID: 17653150 [No Abstract] [Full Text] [Related]
42. Harvard drops plans to join genetic firm. Am Med News; 1980 Nov; 23(46):6. PubMed ID: 11645439 [No Abstract] [Full Text] [Related]
43. A commercial debut for DNA technology. Bus Week; 1977 Dec; (2513):. PubMed ID: 11661586 [No Abstract] [Full Text] [Related]
44. Patent law--claim construction--U.S. District Court for the District of Massachusetts finds conflict on Federal Circuit and holds that product-by-process claims are not limited by their process steps. -- Trustees of Columbia University v. Roche Diagnostics GmbH, 126 F. Supp. 2d 16 (D. Mass. 2000). Harv Law Rev; 2002 Jan; 115(3):923-30. PubMed ID: 11958232 [No Abstract] [Full Text] [Related]
46. Homo economicus: commercialization of body tissue in the age of biotechnology. Nelkin D; Andrews L Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768 [TBL] [Abstract][Full Text] [Related]
47. The Russian [microorganisms] are coming. Goldstein JA Recomb DNA Tech Bull; 1982 Jun; 5(2):85-88. PubMed ID: 6959204 [No Abstract] [Full Text] [Related]
48. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse. Blaug S; Chien C; Shuster MJ Nat Biotechnol; 2004 Jun; 22(6):761-4. PubMed ID: 15175696 [No Abstract] [Full Text] [Related]
50. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
51. Conflict of interest rules seen by some as too stringent. Willyard C Nat Med; 2009 Jul; 15(7):709. PubMed ID: 19584838 [No Abstract] [Full Text] [Related]
52. Need to strike balance with industry-academia rules. Leuchter A; Levey GS Nature; 2007 Oct; 449(7163):658. PubMed ID: 17928837 [No Abstract] [Full Text] [Related]
53. Life can be patented in the US. Cookson C New Sci; 1979 Apr; 82(1150):100-1. PubMed ID: 11663917 [No Abstract] [Full Text] [Related]
54. Bioethics: centres reveal sponsors but not policy. Sharpe VA Nature; 2002 Aug; 418(6898):583. PubMed ID: 12167830 [No Abstract] [Full Text] [Related]
55. Medicine. A bumper crop of conflicts. Marshall E Science; 2008 May; 320(5876):602-3. PubMed ID: 18451276 [No Abstract] [Full Text] [Related]
56. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials. Cote A Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817 [No Abstract] [Full Text] [Related]
57. Patents--patentable subject matter--living man-made organisms held to be patentable subject matter under 35 U.S.C. Section 101. Day MT Marquette Law Rev; 1980; 63(4):711-30. PubMed ID: 11662894 [No Abstract] [Full Text] [Related]
58. Divided loyalties: trust in science is being eroded. How can we restore it? New Sci; 2005 Feb 26-Mar 4; 185(2488):3. PubMed ID: 15839009 [No Abstract] [Full Text] [Related]
59. Untainted by money. Loehle C New Sci; 1997 Aug; 155(2095):44. PubMed ID: 11656796 [No Abstract] [Full Text] [Related]
60. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform. Maatz CT High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]